AIMC Topic: Zoledronic Acid

Clear Filters Showing 1 to 2 of 2 articles

Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study/SPCG11.

European urology oncology
BACKGROUND: Owing to the large variation in treatment response among patients with high-risk prostate cancer, it would be of value to use objective tools to monitor the status of bone metastases during clinical trials. Automated Bone Scan Index (aBSI...

In Silico Digital Twins of Bone Metastasis Enable Investigation of Tumor Progression and Therapy Response.

Cancer research
UNLABELLED: Bone metastasis (BM) is a leading cause of morbidity and mortality in patients with prostate and renal cancer. The complex and dynamic biological processes driving its progression present significant challenges for both understanding and ...